Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137786 · ClinicalTrials.gov registry record · Phase 4
Kidney Damage in Patients With Normal eGFR
A Phase 4 study of Coronary Artery Stenosis, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- Phase 4
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT01137786 is a Phase 4 study of Coronary Artery Stenosis that has completed, run by Bracco Diagnostics. The registered enrollment target is 49 participants, below the 1,654-participant average among 4 other Coronary Artery Stenosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01137786, a Phase 4 study of Coronary Artery Stenosis, has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study, randomized, double-blind, parallel group comparison of two iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled must have normal eGFR. Statistical summaries will be presented to analyse the various laboratory tests for the two groups.
Conditions Studied
Interventions
- DRUG Non ionic contrast media comparator
Study Locations (1)
Illinois
- Prairie Cardiovascular Consultants, Ltd. - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01137786
The ClinicalTrials.gov registry entry for NCT01137786 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,654-participant average among 4 other Coronary Artery Stenosis trials with a reported enrollment target (97% lower). The listed sponsor is Bracco Diagnostics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Non ionic contrast media comparator is the first listed.
NCT01137786 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01137786 about?
NCT01137786 is a clinical study titled "Kidney Damage in Patients With Normal eGFR". This is a pilot study, randomized, double-blind, parallel group comparison of two iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled must have normal eGFR. Statistical summaries will be presented to analyse the various laboratory tests for the two g...
What is the current status of trial NCT01137786?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2010-12. Estimated completion is 2012-04.
What conditions does trial NCT01137786 study?
This clinical trial studies the following conditions: Coronary Artery Stenosis.
What interventions are being tested in trial NCT01137786?
The interventions under investigation include: Non ionic contrast media comparator (DRUG).
Who is sponsoring clinical trial NCT01137786?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01137786 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
RECRUITING · NA
-
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions
COMPLETED · NA
-
A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions
COMPLETED
-
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.